Form 8-K - Current report:
SEC Accession No. 0001104659-25-064427
Filing Date
2025-07-01
Accepted
2025-07-01 07:47:29
Documents
17
Period of Report
2025-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519325d1_8k.htm   iXBRL 8-K 41686
2 EXHIBIT 10.1 tm2519325d1_ex10-1.htm EX-10.1 24215
3 EXHIBIT 10.2 tm2519325d1_ex10-2.htm EX-10.2 106011
4 EXHIBIT 99.1 tm2519325d1_ex99-1.htm EX-99.1 11058
5 GRAPHIC tm2519325d1_ex10-1img001.jpg GRAPHIC 3585
6 GRAPHIC tm2519325d1_ex99-1img001.jpg GRAPHIC 3060
  Complete submission text file 0001104659-25-064427.txt   397064

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA zura-20250625.xsd EX-101.SCH 3011
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250625_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250625_pre.xml EX-101.PRE 22356
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2519325d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 251094178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)